Skip to main content
. 2024 Jul 3;28(13):e18516. doi: 10.1111/jcmm.18516

FIGURE 9.

FIGURE 9

Validation of S100A16's oncogenic role in LUAD through targeted knockdown. (A) Reduction in S100A16 expression in A549 and H1299 cells post‐S100A16 knockdown. (B, C) Colony formation assays demonstrating that S100A16 knockdown notably inhibits LUAD cell proliferation. (D, E) Wound healing assays assess the migratory potential of A549 and H1299 cells following si‐S100A16 transfection. (F‐H) Transwell assays evaluate the migration and invasion capabilities of S100A16‐knockdown A549 and H1299 cells.